Leveraging their ultra-rapid and formulation independent delivery technology, Suono Bio is developing therapeutic products for inflammatory-mediated diseases. The Suono Bios platform is designed to enable ultra-rapid delivery of therapeutics, including proteins and nucleic acids, to the gastrointestinal (GI) trac - making possible rapid, localized delivery of small molecules, biologics, and nucleic acids and gene therapies without the need for encapsulation of the therapeutic. Preclinical studies demonstrated the capacity to deliver small molecules, proteins, vaccines, and nucleic acids locally and systemically, validating further development of the system
